A Cellular Basis for the Potential Atherogenicity of Triglyceride-Rich Lipoproteins

  • Sandra H. Gianturco
  • William A. Bradley
Conference paper


Two potential intiating events in atherosclerosis are endothelial injury and the accumulation of lipid-filled foam cells in the arterial intima. Ross and Glomset suggested that atherosclerosis may be a response to some form of endothelial injury (1). By this mechanism, changes in endothelial permeability could expose the arterial intima, the site of plaque initiation, to all blood components, including monocytes, lipoproteins, platelets, and coagulation factors with ensuing lipid accumulation and fibrin deposition. A second important initiating event in atherosclerosis is the accumulation of foam cells in the intima of the arterial wall (2–4). Many arterial foam cells are monocyte-derived macrophages that are engorged with cholesteryl ester (5). LDL are the major carriers of cholesterol in the blood and have long been considered to be the primary atherogenic lipoprotein. This represents a paradox in terms of the initiation of atherosclerosis, however, since native, unmodified LDL are not toxic in endothelial cells and do not produce foam cells in vitro when incubated with macrophages.


Cholesteryl Ester Foam Cell Cholesteryl Ester Hydrolase Cholesteryl Ester Hydrolase Activity Lesteryl Ester 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ross R, Glomset JA (1973) Atherosclerosis and the arterial smooth muscle cell. Science 180:1332–1339PubMedCrossRefGoogle Scholar
  2. 2.
    Gerrity, RG (1981) The role of monocyte in athero-genesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Clin Pathol 103(2):181–190Google Scholar
  3. 3.
    Faggiotto A and Ross R (1984) Studies of hypercholesterolemia in the nonhuman primate. Arterosclerosis 4:323–340CrossRefGoogle Scholar
  4. 4.
    Brown MS, Goldstein JL (1983) Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Am Rev Biochem 52:223–261CrossRefGoogle Scholar
  5. 5.
    Fowler S, Shio H and Haley NJ (1979) Characterization of lipid-laden aortic cells from cholesterol-fed rabbits. Laboratory Investigation 41(4):372–378PubMedGoogle Scholar
  6. 6.
    Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D (1984) Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density. Proc Natl Acad Sci USA 81:3883–3887PubMedCrossRefGoogle Scholar
  7. 7.
    Fogelman AM, Shechter I, Seager J, Hokom M, Child JS, Edwards, PA (1980) Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc Natl Acad Sci USA 77:2214–2218PubMedCrossRefGoogle Scholar
  8. 8.
    Hessler JR, Morel DW, Lewis LJ, Chisolm, GM (1983) Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis 3:215–222Google Scholar
  9. 9.
    Gianturco SH, Bradley WA, Gotto AM Jr, Morrisett JD, Peavy DL (1982) Hypertriglyceridemic very low density lipoproteins induce triglyceride synthesis and accumulation in mouse peritoneal macrophages. J Clin Invest 70:168–178PubMedCrossRefGoogle Scholar
  10. 10.
    Nestel PJ, Billington T, Bazelmans J (1985) Metabolism of human plasma triacylglycerol-rich lipoproteins in rodent macrophages: capacity for interaction at β-VLDL receptor. Biochim Biophys Acta 837:314–324PubMedGoogle Scholar
  11. 11.
    Van Lenten BJ, Fegelman AM, Hokom MM, Benson L, Haberland ME, Edwards PA (1983) Regulation of the uptake and degradation of β-very low density lipoprotein in human monocyte-macrophages. J Biol Chem 258:5151–5157.PubMedGoogle Scholar
  12. 12.
    Gianturco SH, Brown SA, Via DP, Bradley WL (1986) The β-VLDL receptor pathway of murine P388D1 macrophages. J Lipid Res 27:412–420PubMedGoogle Scholar
  13. 13.
    Parker F, Bagdade JD, Odland GF, Bierman EL (1970) Evidence for the chylomicron origin of lipids accumulating in diabetic eruptive xanthomas: a correlative lipid biochemical, histochemical, and electron microscopic study. J Clin Invest 49:2172–2187PubMedCrossRefGoogle Scholar
  14. 14.
    Shen BW, Scanu AM, Kezdy FJ (1977) Structure of human serum lipoproteins inferred from compositional analysis. Proc Natl Acad Sci USA 74:837–841PubMedCrossRefGoogle Scholar
  15. 15.
    Eisenberg S, Gavish D, Oschry Y, Fainaru M, Deckelbaum RJ (1984) Abnormalities in very low, low, and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment. J Clin Invest 74:470–482PubMedCrossRefGoogle Scholar
  16. 16.
    Gianturco SH, Gotto AM Jr, Jackson RL, Patsch JR, Sybers HD, Taunton OD, Yeshurun DL, Smith LC (19 78) Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low denisty lipoproteins of subjects with hypertriglyceridemia. J Clin Invest 61:320–328PubMedCrossRefGoogle Scholar
  17. 17.
    Gianturco SH, Packard CJ, Shepherd J, Smith LC, Catapano AL, Sybers HD, Gotto AM Jr (1980) Abnormal suppression of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by hypertriglyceridemic very low density lipoprotein subclasses. Lipids 15:456–463PubMedCrossRefGoogle Scholar
  18. 18.
    Gianturco SH, Brown FB, Gotto AM Jr, Bradley WA (1982) Receptor-mediated uptake of hypertriglyceridemic very low density lipoproteins by normal human fibroblasts. J Lipid Res 23:984–993PubMedGoogle Scholar
  19. 19.
    Poyser A, Nestel PJ (1979) Metabolism of very low density lipoproteins by human mononuclear cells. Artery 6:122–143Google Scholar
  20. 20.
    Krul ES, Tikkanen MJ, Cole TG, Davie JM, Schonfeld G (1985) Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins. J Clin Invest 75:361–369PubMedCrossRefGoogle Scholar
  21. 21.
    Gianturco SH, Gotto AM Jr, Hwang S-LC, Karlin JB, Lin AHY, Prasad SC, Bradley WA (1983) Apolipoprotein E mediates uptake of Sf100–400 hypertriglyceridemic very low density lipoproteins by the low density lipoprotein receptor pathway in normal human fibroblasts. J Biol Chem 258:4526–4533PubMedGoogle Scholar
  22. 22.
    Bradley WA, Hwang S-LC, Karlin JB, Lin AHY, Prasad SC, Gotto AM Jr, Gianturco SH (1984) Low-density lipoprotein receptor binding determinants switch from apolipoprotein B during conversion of hypertriglyceridemic very-low-density lipoportein to low-density lipoproteins. J Biol Chem 259:14728–14735PubMedGoogle Scholar
  23. 23.
    Brown MS, Goldstein JL (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232 (4746):34–47PubMedCrossRefGoogle Scholar
  24. 24.
    Gianturco SH, Eskin SG, Navarro LT, Lahart CJ, Smith LC, Gotto AM Jr (1980) Abnormal effects of hypertri-acylglycerolemic very low-density lipoproteins on 3-hydroxy-3-methylglutaryl-CoA reductase activity and viability of cultured bovine aortic endothelial cells. Biochim Biophys Acta 618:14 3–152Google Scholar
  25. 25.
    Glum CB, Aron L, Sciacca R (1980) Radioimmunoassay studies of human apolipoprotein E. J Clin Invest 66:1240–1250CrossRefGoogle Scholar
  26. 26.
    Schonfeld G, Patsch W, Pfleger B, Witztum JL, Weidman SW (1979) Lipolysis produces changes in the immuno-reactivity and cell reactivity of very low density lipoproteins. J Clin Invest 64:1288–1297PubMedCrossRefGoogle Scholar
  27. 27.
    Reardon MF, Fridge NH, Nestel PJ (1978) Catabolism of very low density lipoprotein B apoprotein in man. J Clin Invest 61:850–860PubMedCrossRefGoogle Scholar
  28. 28.
    Fredrickson DS, Goldstein JL, Brown MS (1978) The familial hyperlipoproteinemias. In: Stanbury JG, Syngaarden MF, Fredrickson DS (eds) The Metabolic Basis of Inherited Diseases, 4th edition. McGraw-Hill, New York, pp 604–655Google Scholar
  29. 29.
    Khoo, JC, Vance JE, Mahoney, EM, Jensen D, Wancewicz E, Steinberg D (1984) Neutral triglyceride lipase in macrophages. Arteriosclerosis 4:34–40PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1990

Authors and Affiliations

  • Sandra H. Gianturco
  • William A. Bradley

There are no affiliations available

Personalised recommendations